Atlas Venture — 2018 Investments
3 investments dated 2018 · listed companies and verified rows first · show all
Akero Therapeutics, Inc.Dec 2018SEC filingmedium confidence
South San Francisco, US
Board seatKevin Bitterman· per SEC Form D · $45.5M raise · filed Dec 2018
Akriveia TherapeuticsJan 2018SEC filinghigh confidence
BiotechSkillman, US
Thomas Beck(Director)Benjamin Auspitz(Director)Simon Tomlinson(Executive Officer, Director)
Board seatDavid Grayzel· per SEC Form D · $22.5M raise · filed Jan 2018
IFM TreJul 2018SEC filingmedium confidence
BiotechBoston, US
Jean-Francois Formela(Director)Vincent Miles(Director)Gary D Glick(Executive Officer, Director)
Board seatJean-François Formela· per SEC Form D · filed Aug 2018
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.